within Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G03D_Progestogens.G03DB08_Dienogest;

model Dienogest
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C_enteral(
    weight = 70,
    F = 0.91,
    Cl = 9.722222222222222e-07,
    adminDuration = 600,
    adminMass = 2 / 1000000,
    adminCount = 1,
    Vd = 0.046,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.043333333333333335,
    Tlag = 10.200000000000001,
    Vdp = 0.132,
    k12 = 2.1666666666666665e-06,
    k21 = 2.1666666666666665e-06);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Dienogest</td></tr><tr><td>ATC code:</td><td>G03DB08</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>2</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>46</td><td>L</td></tr>
    <tr><td>clearance:</td><td>3.5</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Dienogest is a synthetic progestogen (progestin) used primarily for the treatment of endometriosis and as a component in contraceptive preparations. It is approved and currently used in several countries for these indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are reported for healthy adult women after oral administration of dienogest, 2 mg daily dosing.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.G.G03DB08 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Dienogest;
